Exelixis (EXEL) Assets (2010 - 2026)
Exelixis' (EXEL) quarterly Assets came in at $2.6 billion in Q2 2026, down 8.59% year-on-year from $2.8 billion in Q2 2025, and down 8.82% quarter-over-quarter from $2.8 billion in Q1 2026.
Exelixis (EXEL) Assets (2010 - 2026) Analysis & Trends
Exelixis' Assets history runs 17 years deep, the most recent figure standing at $2.6 billion for Q2 2026.
- On a quarterly basis, Assets fell 8.59% year-over-year to $2.6 billion in Q2 2026; TTM through Apr 2026 was $2.6 billion, a 8.59% decrease from a year earlier, with the FY2026 full-year figure at $2.8 billion, down 3.5% from the prior year.
- Assets fell to $2.6 billion in Q2 2026 per EXEL's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Assets topped out at $3.1 billion in Q1 2023 and bottomed at $2.6 billion in Q2 2026.
- The 5-year median for Assets is $2.9 billion (2022), against an average of $2.9 billion.
- Across the five-year window, Assets gained 21.72% in 2022 and dropped 11.75% in 2024, its largest moves.
- Year by year, Assets stood at $3.1 billion in 2022, then decreased by 4.2% to $2.9 billion in 2023, then advanced by 0.61% to $3.0 billion in 2024, then slipped by 4.62% to $2.8 billion in 2025, then slipped by 8.14% to $2.6 billion in 2026.
- Per Business Quant, the three latest EXEL Assets figures stand at $2.6 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 2.59 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.59 Bn |
| Jan 2, 2026 | 2.84 Bn |
| Oct 3, 2025 | 2.82 Bn |
| Jul 4, 2025 | 2.68 Bn |
| Apr 4, 2025 | 2.84 Bn |
| Jan 3, 2025 | 2.95 Bn |
| Sep 27, 2024 | 2.96 Bn |
| Jun 28, 2024 | 2.77 Bn |
| Mar 29, 2024 | 2.80 Bn |
| Dec 29, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.98 Bn |
| Jun 30, 2023 | 3.14 Bn |
| Mar 31, 2023 | 3.14 Bn |
| Dec 30, 2022 | 3.07 Bn |
| Sep 30, 2022 | 2.96 Bn |
| Jul 1, 2022 | 2.88 Bn |
| Apr 1, 2022 | 2.65 Bn |
| Dec 31, 2021 | 2.62 Bn |
| Oct 1, 2021 | 2.45 Bn |
| Jul 2, 2021 | 2.37 Bn |